Cargando…

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer

OBJECTIVE: Optimal debulking with no macroscopic residual disease strongly predicts ovarian cancer survival. The ability to predict likelihood of optimal debulking, which may be partially dependent on tumor biology, could inform clinical decision-making regarding use of neoadjuvant chemotherapy. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbas-Aghababazadeh, Farnoosh, Sasamoto, Naoko, Townsend, Mary K., Huang, Tianyi, Terry, Kathryn L., Vitonis, Allison F., Elias, Kevin M., Poole, Elizabeth M., Hecht, Jonathan L., Tworoger, Shelley S., Fridley, Brooke L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902593/ https://www.ncbi.nlm.nih.gov/pubmed/36761962 http://dx.doi.org/10.3389/fonc.2023.1090092

Ejemplares similares

Lifetime ovulatory years and ovarian cancer gene expression profiles
por: Sasamoto, Naoko, et al.
Publicado: (2022)

Associations between prediagnostic aspirin use and ovarian tumor gene expression
por: Sasamoto, Naoko, et al.
Publicado: (2023)

Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2018)

Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2019)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

The association of resistance training with risk of ovarian cancer
por: Buras, Andrea L, et al.
Publicado: (2021)

Evaluation of CA125 in relation to pain symptoms among adolescents and young adult women with and without surgically-confirmed endometriosis
por: Sasamoto, Naoko, et al.
Publicado: (2020)

A prospective cohort study of dietary indices and incidence of epithelial ovarian cancer
por: Xie, Jing, et al.
Publicado: (2014)

The inflammatory potential of diet and ovarian cancer risk: results from two prospective cohort studies
por: Tabung, Fred K, et al.
Publicado: (2017)

Quinary debulking for epithelial ovarian cancer
por: Edwards, James M., et al.
Publicado: (2012)

Estimating the local false discovery rate via a bootstrap solution to the reference class problem
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2018)

The impact of violating the independence assumption in meta-analysis on biomarker discovery
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

Cohort profile: The Endometriosis pain QUality aftEr Surgical Treatment (EndoQUEST) Study
por: Shafrir, Amy L., et al.
Publicado: (2022)

Secondary debulking for ovarian carcinoma relapse: The R-R dilemma – is the prognosis different for residual or recurrent disease?
por: Spiliotis, John D., et al.
Publicado: (2019)

Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases
por: Shafrir, Amy L, et al.
Publicado: (2016)

The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
por: Yang, Shi‐Ping, et al.
Publicado: (2022)

The Association Between Talc Use and Ovarian Cancer: A Retrospective Case–Control Study in Two US States
por: Cramer, Daniel W., et al.
Publicado: (2016)

Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer
por: Arab, Maliheh, et al.
Publicado: (2018)

Does Endometriosis Hinder Successful Ovarian Debulking Surgery?
por: Sananpanichkul, Panya, et al.
Publicado: (2018)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery
por: Fagotti, A, et al.
Publicado: (2016)

Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies
por: Fortner, Renée T., et al.
Publicado: (2019)

Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data
por: Wilson, Christopher M., et al.
Publicado: (2021)

Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review
por: Terry, Kathryn L., et al.
Publicado: (2004)

Diaphragm hernia after debulking surgery in patients with ovarian cancer
por: Ehmann, Sarah, et al.
Publicado: (2021)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Intake of dietary flavonoids and risk of epithelial ovarian cancer(1)(2)(3)(4)
por: Cassidy, Aedín, et al.
Publicado: (2014)

DNA Methylation in Ovarian Cancer Susceptibility
por: Reid, Brett M., et al.
Publicado: (2020)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
por: Günakan, Emre, et al.
Publicado: (2020)

Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
por: Yokosu, Kota, et al.
Publicado: (2021)

Postoperative paralytic ileus following debulking surgery in ovarian cancer patients
por: Egger, Eva K., et al.
Publicado: (2022)

Surrogates of Long-Term Vitamin D Exposure and Ovarian Cancer Risk in Two Prospective Cohort Studies
por: Prescott, Jennifer, et al.
Publicado: (2013)

IgA transcytosis and antigen recognition govern ovarian cancer immunity
por: Biswas, Subir, et al.
Publicado: (2021)

Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease
por: Geady, Caryn, et al.
Publicado: (2023)

Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer
por: Derlatka, Pawel, et al.
Publicado: (2016)

Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
por: Tsoi, Tung Tung, et al.
Publicado: (2020)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

Gastric Volvulus: A Delayed Surgical Complication After Debulking and Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
por: Ghattas, Souad, et al.
Publicado: (2023)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5gdjp33c1td38ilq89kl710h5p